304 related articles for article (PubMed ID: 10594856)
1. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome.
Valentini V; Morganti AG; De Franco A; Coco C; Ratto C; Battista Doglietto G; Trodella L; Ziccarelli L; Picciocchi A; Cellini N
Cancer; 1999 Dec; 86(12):2612-24. PubMed ID: 10594856
[TBL] [Abstract][Full Text] [Related]
2. Combined-modality therapy in locally advanced primary rectal cancer.
Ratto C; Valentini V; Morganti AG; Barbaro B; Coco C; Sofo L; Balducci M; Gentile PC; Pacelli F; Doglietto GB; Picciocchi A; Cellini N
Dis Colon Rectum; 2003 Jan; 46(1):59-67. PubMed ID: 12544523
[TBL] [Abstract][Full Text] [Related]
3. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.
Valentini V; Coco C; Picciocchi A; Morganti AG; Trodella L; Ciabattoni A; Cellini F; Barbaro B; Cogliandolo S; Nuzzo G; Doglietto GB; Ambesi-Impiombato F; Cosimelli M
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):664-74. PubMed ID: 12062610
[TBL] [Abstract][Full Text] [Related]
4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
5. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment.
Sanfilippo NJ; Crane CH; Skibber J; Feig B; Abbruzzese JL; Curley S; Vauthey JN; Ellis LM; Hoff P; Wolff RA; Brown TD; Cleary K; Wong A; Phan T; Janjan NA
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):176-83. PubMed ID: 11516868
[TBL] [Abstract][Full Text] [Related]
6. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M
Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571
[TBL] [Abstract][Full Text] [Related]
7. Concurrent 5-fluorouracil, mitomycin C and radiation, with or without brachytherapy, in recurrent endometrial cancer: a scoring system to predict clinical response and outcome.
Smaniotto D; D'Agostino G; Luzi S; Valentini V; Macchia G; Mangiacotti MG; Margariti PA; Ferrandina G; Scambia G
Tumori; 2005; 91(3):215-20. PubMed ID: 16206643
[TBL] [Abstract][Full Text] [Related]
8. Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy.
Pacelli F; Tortorelli AP; Rosa F; Bossola M; Sanchez AM; Papa V; Valentini V; Doglietto GB
Ann Surg Oncol; 2010 Jan; 17(1):152-62. PubMed ID: 19834766
[TBL] [Abstract][Full Text] [Related]
9. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
Glynne-Jones R; Falk S; Maughan TS; Meadows HM; Sebag-Montefiore D
Br J Cancer; 2007 Feb; 96(4):551-8. PubMed ID: 17262086
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer.
Suzuki K; Gunderson LL; Devine RM; Weaver AL; Dozois RR; Ilstrup DM; Martenson JA; O'Connell MJ
Cancer; 1995 Feb; 75(4):939-52. PubMed ID: 7531113
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of interstitial pulsed dose rate brachytherapy in multimodality treatment of locally advanced primary or recurrent rectal and sigmoid cancer with high risk of incomplete microscopic resection.
Nielsen MB; Rasmussen PC; Tanderup K; Nielsen SK; Fokdal L; Laurberg S; Lindegaard JC
Acta Oncol; 2016 Dec; 55(12):1408-1413. PubMed ID: 27537776
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers.
Mohiuddin M; Hayne M; Regine WF; Hanna N; Hagihara PF; McGrath P; Marks GM
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1075-80. PubMed ID: 11072165
[TBL] [Abstract][Full Text] [Related]
13. Concurrent 5-fluorouracil, mitomycin C and radiation with or without brachytherapy in recurrent cervical cancer: a scoring system to predict clinical response and outcome.
Smaniotto D; D'Agostino G; Luzi S; Valentini V; Macchia G; Mantini G; Margariti PA; Ferrandina G; Scambia G
Tumori; 2005; 91(4):295-301. PubMed ID: 16277092
[TBL] [Abstract][Full Text] [Related]
14. Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer.
Weinstein GD; Rich TA; Shumate CR; Skibber JM; Cleary KR; Ajani JA; Ota DM
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):197-204. PubMed ID: 7721616
[TBL] [Abstract][Full Text] [Related]
15. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer.
Harrison LB; Minsky BD; Enker WE; Mychalczak B; Guillem J; Paty PB; Anderson L; White C; Cohen AM
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):325-30. PubMed ID: 9788411
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
17. "Sandwich" preoperative and postoperative combined chemotherapy and radiation in tethered and fixed rectal cancer: impact of treatment intensity on local control and survival.
Chan AK; Wong AO; Langevin JM; Jenken DA; Khoo R; Heine JA; Buie WD; Johnson DR
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):629-37. PubMed ID: 9112462
[TBL] [Abstract][Full Text] [Related]
18. Prospective single-arm study of intraoperative radiotherapy for locally advanced or recurrent rectal cancer.
Tan J; Heriot AG; Mackay J; Van Dyk S; Bressel MA; Fox CD; Hui AC; Lynch AC; Leong T; Ngan SY
J Med Imaging Radiat Oncol; 2013 Oct; 57(5):617-25. PubMed ID: 24119279
[TBL] [Abstract][Full Text] [Related]
19. Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study.
Chan AK; Wong AO; Langevin J; Jenken D; Heine J; Buie D; Johnson DR
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):843-56. PubMed ID: 11020583
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemoradiation plus intraoperative radiotherapy versus adjuvant chemoradiation alone in patients with locally advanced rectal cancer.
Zhang Q; Tey J; Yang Z; Li P; Peng L; Fu S; Huang G; Xiong F; Lu JJ
Am J Clin Oncol; 2015 Feb; 38(1):11-6. PubMed ID: 25616201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
